Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: Separation from native lipoprotein by affinity chromatography-Reference-Cited by-同舟云学术

Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: Separation from native lipoprotein by affinity chromatography

Published:1990-03 Issue:3 Volume:167 Page:1122-1127
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Tertov Vladimir V.,Sobenin Igor A.,Tonevitsky Alexander G.,Orekhov Alexander N.,Smirnov Vladimir N.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference17 articles.

1. Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.

2. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells

3. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients

4. High-mannose structure of apolipoprotein-B from low-density lipoproteins of human plasma

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis;Current Medicinal Chemistry;2024-03-15

2. Systematic Assessment of Protein C-Termini Mutated in Human Disorders;Biomolecules;2023-02-12

3. Lipoprotein sialylation in atherosclerosis: Lessons from mice;Frontiers in Endocrinology;2022-09-06

4. Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov;Biomedicines;2022-05-19

5. Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy;CURR MED CHEM;2021